A clinical study to assess the safety and effectiveness of tbo-filgrastim in infants,children and adolescents with solid tumors without bone marrow involvement
- Registry ID
- EUCTR2014-001772-55
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- TEVA Pharmaceutical Industries Ltd
- Start date
- 2015-01-26
- Completion date
- 2017-04-03
- Last update
- 2026-08-16
Conditions
- Chemotherapy induced Neutropenia
Summary
The primary objective of this study is to assess the safety and tolerability of 5 μg/kg tbo-filgrastim in the pediatric population with solid tumors without bone marrow involvement.
Locations
- , , Poland
- , , Croatia
- , , Romania
- , , Hungary
- , , Bulgarian Drug Agency
View on source registry